Leverkusen, October 30, 2019 – Bayer has made progress in all key areas and is on track both operationally and strategically. “Bayer had a successful third quarter,” Werner Baumann, Chairman of the Board of Management, said on Wednesday during the news conference call on the quarterly figures. “We increased the Group’s sales and EBITDA before special […]
Whippany (July 25, 2019) — The following is Bayer’s statement regarding a ruling in Pilliod v. Monsanto by Judge Winifred Smith in the Superior Court of the State of California for the County of Alameda to reduce the punitive, non- economic, and future medical damages in the case. The court reduced Mr. Pilliod’s non-economic damages from $18 million to $6.1 million and […]
Whippany, July 15, 2019 – The following is Bayer’s statement regarding the ruling by U.S. District Judge Vince Chhabria in the District Court for the Northern District of California on Monsanto’s post-trial motions in Hardeman v. Monsanto. The court reduced the punitive damages to $20 million, which reduces the overall verdict from $80.267 million to […]
Whippany, N.J., June 18, 2019 – In post-trial motions filed in Pilliod v. Monsanto, Monsanto urged California Superior Court Judge Winifred Smith to reverse the jury verdict and enter judgment for Monsanto or order a new trial. The company argues in its briefs that the “verdicts do not reflect the evidence presented in the case; they reflect […]
Whippany, N.J., June 3, 2019 – In post-trial motions recently filed in Hardeman v. Monsanto, Monsanto urged federal district court Judge Vince Chhabria who is presiding over the MDL in the Northern District of California to reverse the jury verdict and enter judgment for Monsanto, or in the alternative, order a new trial. The company […]
Leverkusen / Whippany, May 13, 2019 – Bayer released the following statement in reaction to a jury verdict in favor of the plaintiffs in the case of Pilliod v. Monsanto, a trial conducted before Judge Winifred Smith in the Superior Court of the State of California for the County of Alameda. This is the first […]
EPA assessment ‘more robust’ and ‘more transparent’ than IARC, agency says Whippany, N.J., April 30, 2019 – Bayer today issued the following statement regarding an interim registration review decision by the U.S. Environmental Protection Agency (EPA) to reapprove glyphosate for use in the U.S. The decision was accompanied by public comments by EPA Assistant Administrator for […]
The following is Bayer’s statement regarding Judge Winifred Smith’s ruling on Monsanto’s Motion for Nonsuit in the Pilliod glyphosate-based herbicide trial in the Superior Court of the State of California for the County of Alameda. “Bayer is disappointed with the Court’s decision, as we believe that the plaintiffs have not presented sufficient evidence to support […]
The following is Bayer’s statement regarding Monsanto’s Motion for Nonsuit in the Pilliod glyphosate-based herbicide trial before Judge Winifred Smith in the Superior Court of the State of California for the County of Alameda. “Bayer believes that the plaintiffs have failed to provide sufficient evidence to support their claims, which should be dismissed on multiple […]
Company Says Evidence Falls Short of the Burden Required to Support Liability Claims, Causation and Damages Given International Regulatory Consensus and Extensive Body of Favorable Science Related Motion For Judicial Notice Highlights Unusual Efforts to Persuade the Trial Court to Change Its Tentative Ruling on Post-Trial Motions Whippany, N.J., April 24, 2019 – In a forceful […]
Bayer today provided an update on its five-point plan to address future Roundup™ litigation risk after its May 27th decision to withdraw from the national class process. The company is now in more control of important aspects of the risk mitigation process and has sketched out two basic scenarios going forward to provide a path to closure of this litigation. The first scenario is based on obtaining a favorable decision by the United States Supreme Court on a cross-cutting issue like federal preemption which would effectively and largely end the U.S. Roundup™ litigation. The second scenario assumes that the Supreme Court either declines to hear the Hardeman case or issues a ruling in favor of plaintiff – in that case the company would activate its own claims administration program.
Read about the five-point plan here.